Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Scott Hauenstein

Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

Clinical Gastroenterology and Hepatology

Hepatology

Gastroenterology

2014

English

Kinetic Quality Control of Anticodon Recognition by a Eukaryotic Aminoacyl-tRNA Synthetase

Journal of Molecular Biology

English

Related publications

Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-Making for IBD Outpatients on Maintenance Infliximab Therapy

Inflammatory Bowel Diseases

English

The Combined Use of Disease Activity and Infliximab Serum Trough Concentrations for Early Prediction of (Non-)Response to Infliximab in Rheumatoid Arthritis

British Journal of Clinical Pharmacology

Pharmacology

2013

English

PWE-109 Measurement of Infliximab and Anti-Infliximab Antibodies - Analytical Aspects and Clinical Implications: Abstract PWE-109 Table

Gut

Gastroenterology

2013

English

Detection of Anti-Infliximab Antibodies Is Impacted by Antibody Titer, Infliximab Level and IgG4 Antibodies: A Systematic Comparison of Three Different Assays

Therapeutic Advances in Gastroenterology

Gastroenterology

2016

English

Higher Infliximab Trough Levels Are Associated With Perianal Fistula Healing in Patients With Crohn's Disease

Alimentary Pharmacology and Therapeutics

English

Editorial: Infliximab Trough Cut-Off for Perianal Crohn's Disease - Another Piece of the Therapeutic Drug Monitoring-Guided Infliximab Dosing Puzzle

Alimentary Pharmacology and Therapeutics

English

Letter: New Thresholds Need to Be Defined When Using Point of Care Assays to Monitor Infliximab Trough Levels in IBD Patients

Alimentary Pharmacology and Therapeutics

English

Infliximab in Active Early Rheumatoid Arthritis

Annals of the Rheumatic Diseases

English

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine

Medicine

2005

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Scott Hauenstein

Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

Kinetic Quality Control of Anticodon Recognition by a Eukaryotic Aminoacyl-tRNA Synthetase

Related publications

Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-Making for IBD Outpatients on Maintenance Infliximab Therapy

The Combined Use of Disease Activity and Infliximab Serum Trough Concentrations for Early Prediction of (Non-)Response to Infliximab in Rheumatoid Arthritis

PWE-109 Measurement of Infliximab and Anti-Infliximab Antibodies - Analytical Aspects and Clinical Implications: Abstract PWE-109 Table

Detection of Anti-Infliximab Antibodies Is Impacted by Antibody Titer, Infliximab Level and IgG4 Antibodies: A Systematic Comparison of Three Different Assays

Higher Infliximab Trough Levels Are Associated With Perianal Fistula Healing in Patients With Crohn's Disease

Editorial: Infliximab Trough Cut-Off for Perianal Crohn's Disease - Another Piece of the Therapeutic Drug Monitoring-Guided Infliximab Dosing Puzzle

Letter: New Thresholds Need to Be Defined When Using Point of Care Assays to Monitor Infliximab Trough Levels in IBD Patients

Infliximab in Active Early Rheumatoid Arthritis

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis